Does Age Affect Cancer Genomics?

BY GARETT FRAMPTON
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.
 
PUBLISHED: OCTOBER 04, 2017


Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.

In a study of more than 100,000 people, Frampton and his team found that younger patients (typically those in their 30s and 40s) tended to have germline alterations, while people who were in their 50s and 60s were more likely to have a much different genetic makeup.

Establishing the methodology for this kind of research is particularly important, Frampton says, as Foundation Medicine will continue to grow its database and take their research to the next steps, which may ultimately play a huge role in treatment decision-making for patients with cancer.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
x-button
 
CURE wants to hear from you! We are inviting you to Share Your Story with the readers of CURE. Submit your personal experience with cancer by visiting Share Your Story
 
Not yet receiving CURE in your mailbox? Sign up to receive CURE Magazine by visiting GetCureNow.com
x
//For side ad protocol